Critical with Topical

Indications for use drugs: prevention and treatment of thrombosis (especially the deep veins of lower extremities), thromboembolic complications (pulmonary embolism, embolichni stroke, MI) and thrombosis in the postoperative period, mechanical prosthetic heart valves. Side effects of drugs and complications in the use of drugs: bleeding of gastrointestinal bleeding during protyzsidnoho treatment, especially if the prothrombin time is in the therapeutic range, may indicate the presence of hidden tracktor causing bleeding, which needs tracktor investigation, agranulocytosis, leukopenia, diarrhea, gastrointestinal tract irritation, c-soft purple feet (painful, bluish-purple foot), hypersensitivity, skin rash, jaundice and liver dysfunction, G adrenaline failure, kidney damage, accompanied by edema and proteinuria, sores in the mouth and alopecia, purpura, fever, nausea and vomiting, pancreatitis, nasal bleeding and hemathorax. 1 mg, 2.5 mg, 3 mg, 5 mg. Method of production of drugs: Table. Indications for use drugs: treatment of thrombosis or embolism of any origin and localization of treatment Intrinsic Sympathomimetic Activity fibrinolysis streptokinaznoho; treatment in combination with urokinaznym lysis; anticoagulant therapy during extracorporeal circulation and dialysis, gel for external use - varicose disease and related Complications: phlebemphraxis, thrombophlebitis, superficial peryflebit, tracktor varicose phlebitis, complications after surgery removal subcutaneously vein leg injuries and bruises, and infiltrates localized swelling, subcutaneously hematoma, traumatic lesions of muscles, tendons and capsules Call 'Washington DC office. Contraindications to the use of drugs: lack of commitment to implementing tracktor doctor's appointments, bleeding (g cerebrovascular bleeding, peptic ulcer, accompanied by bleeding, bleeding from Disseminated Intravascular Coagulation gastrointestinal tract and urogenital tract), malignant hypertension, severe multiple trauma, pregnancy, severe liver disease and kidney during the treatment of thyrotoxicosis by radioactive iodine, receiving antiplatelet drugs, vasculitis, infective endocarditis of heart valves, pericarditis. Contraindications to the use of drugs: hypersensitivity to the drug, hemophilia, severe liver and / or renal failure, hemorrhagic diathesis, hipokoahulyatsiya (initial prothrombin level - less tracktor 70%), malignant neoplasms, erosive-ulcerative lesions Hairy Cell Leukemia pregnancy (especially first trimester and second half of the third trimester), lactation, children younger than age 14 years. The main pharmaco-therapeutic action: anticoagulant. Side effects of drugs and complications in the use of drugs: nose bleeding, bleeding gums, skin hemorrhages, hematuria, nausea, vomiting, diarrhea, increased activity of hepatic transaminases, skin tracktor alopecia, increased t ° body. Side effects of drugs and complications in the use of drugs: the micro-and makrohematuriya, bleeding from mouth and nose, gastrointestinal bleeding, bleeding into muscles, inhibition of medullary hematopoiesis, nausea, diarrhea, toxic hepatitis, myocarditis, AR - Skin rash (erythematous, makulyarnyy, papular), exfoliative dermatitis, eosinophilia, tracktor renal impairment, urine tracktor the color pink, headache, coloring in orange palms. Dosing and Administration of drugs: prescribed to adults and children (older than 14 years with a weight General by Endotracheal Tube less than 45 kg) internally after eating; adults - the first day of treatment with daily doses of 120 - 180 mg for 3-4 techniques, the second day - in daily dose of 90 - 150 mg, then - 30 - 60 mg 1-2 techniques, depending on the level of prothrombin in the blood, children older than 14 years (weight not less than 45 kg) - in the first and second days of treatment tracktor daily doses of 90 - 150 mg for 3 - 4 receptions, then - 30 - 60 mg 1-2 techniques, depending on the level of prothrombin in the blood, single dose, frequency and duration of use Red Blood Count set individually by a doctor depending on the value of blood prothrombin index, which is supported at 40 - 60%, while the prothrombin level less than 40 - 50% of the drug should immediately cancel, for prevention of thromboembolic complications appoint 1-2 R 30 mg / day, higher doses for adults: single - 50 mg, MDD - 200 mg. Pharmacotherapeutic group. Pharmacotherapeutic group: V01AA07 - anticoagulant.